The Playground

    The War on Treatment Is Fiercer Now Than Even Covid Itself


    The War on Treatment Is Fiercer Now Than Even Covid Itself
    By Mary Beth Pfeiffer This article is part of a publishing collaboration between Rescue and Trial Site News. The outstanding reporting by Mary Beth
    trialsitenews.com


    By Mary Beth Pfeiffer


    This article is part of a publishing collaboration between Rescue and Trial Site News. The outstanding reporting by Mary Beth Pfeiffer will be simultaneously published in both outlets. Please subscribe to Rescue and Trial Site News for incisive pandemic reporting.



    Dr. Mollie James turned covid around for her brother, Nick James, by treating him at home with high-dose ivermectin for ten days, hydroxychloroquine for five days, a blood thinner, intravenous vitamin C, and—the ultimate breakthrough— four days of hyperbaric oxygen treatments. He returned to his job as an insurance agent in Iowa the next week. (Photo courtesy of Mollie James)

    Omicron is tearing through the country, with Covid cases quadrupling and quintupling in thirty-five states from last winter’s peak.


    That’s the bad news, but only sort of.


    The good news: For the first time in twenty-two months, experts are uttering words we haven’t heard in answer to the central question: Are we nearing the pandemic’s end?


    “I think we are,” said Dr. Pierre Kory, a pulmonary and critical care specialist and president of the Front Line COVID-19 Critical Care Alliance.


    “I am optimistic for this,” said Dr. Harvey Risch, a Yale epidemiologist and treatment advocate. “The more Omicron cases the better until the peak starts to turn downward.”


    These two early treatment pioneers echo the sentiments of other experts, some guarded but mostly hopeful, that the highly transmissible, less-virulent Omicron may end covid as we know it.


    “I’m so happy that Omicron is milder, that Omicron is winding up the pandemic,” said Dr. Mobeen Syed, known to a half-million subscribers of Drbeen Medical Lectures on YouTube.


    From France, treatment advocate Dr. Christian Perronne, author of the aptly titled, Is There A Mistake They Didn’t Make?, told me, “It could be the end of the pandemic soon.”


    By all indications, the U.S. and Europe—where a “west-to-east tidal wave” is unfolding—will follow the South Africa–United Kingdom model. There, Omicron rose and fell fast, obliterating the more fearsome Delta, and leading to far lower rates of hospitalization and death.


    Experts are anxiously waiting for that to happen in exploding Omicron hot spots like the United States. But one certainty remains. The U.S. and first-world governments still do not want doctors to treat covid early and are doing all it can to stop them.


    This article covers that ongoing problem, how to adapt to a veritable blockade on safe effective generics, and how I got around those obstacles when I got sick.



    At the height of Nick James’s covid illness, he fainted twice, and his sister, Dr. Mollie James, momentarily could find no pulse. She treated him successfully at home with ivermectin, hydroxychloroquine, a blood thinner, intravenous vitamin C, and hyperbaric oxygen. (Photo courtesy of Mollie James)

    ‘I Would Not Be Here’

    When Dr. Mollie James was infected with covid in March of 2020, she was working in an ICU ward in New York City, the hell of the exploding pandemic. She toughed it out because that’s all there was.


    When she got sick again recently, she took a menu of trial-tested generic drugs. By then, she knew early treatments that worked—essential knowledge that is denied today, not by happenstance but by one-size-fits-all vaccine mania.


    Like Dr. James, I got covid in late 2021. I, too, was treated early—before the dreaded drop in blood oxygen that drives the untreated to hospitals. I did fine. Many people my age—north of sixty—have suffered greatly, and some have died because they were not treated at first symptoms.


    Indeed, our two stories of vanquished covid—me vaccinated, Dr. James not—demonstrate what most of the “civilized” world does not know: Covid can be resolved with available drugs and the freedom to use them.


    Dr. James believes she was infected last October while treating her brother, Nick, forty-one, whose severe infection, likely Delta, brought him to the brink. She had worried that her healthy but overweight sibling, he told me, was a “prime candidate for trouble.” At the height of his illness, Nick James could not breathe, fainted twice at home, and his sister momentarily could find no pulse.


    Ultimately, it took high-dose ivermectin for ten days, hydroxychloroquine for five days, a blood thinner, intravenous vitamin C, and—the ultimate breakthrough—four days of hyperbaric oxygen treatments to turn covid around and keep him home. He returned to work as an insurance agent in Iowa the next week; she went back to her clinic.


    How many other doctors, who mostly follow the mainstream dogma against such treatments, would have accomplished that, let alone tried?


    “I feel like I would not be here if it wasn’t for her,” Nick James said.


    Not Just a Cold

    Omicron is undoubtedly different from the Delta variant that had sorely tested the early treatment portfolio. But it also can defy the fabled “just-a-cold” description that, in some cases, may not call for treatment.


    “In November to late December,” Dr. Kory said, “I took my foot off the gas pedal and am now getting patients through with just the first-line treatments from our protocol—the combination of ivermectin, hydroxychloroquine, and fluvoxamine.” With Delta, “I was burning through those and using second-line medicines like dutasteride and spironolactone and even third-line medicines like prednisone in almost all patients. That last wave of Delta was dreadful.”


    Another difference, Kory said: “With Omicron, I worry less about the possibility of them going into the dreaded lung phase.” Symptoms can still be significant—high fever, painful sore throat, and intense fatigue. But, he said, “I have not had to resort to second-line drugs in the last ten days.”


    Other practitioners agreed. Dr. Bruce Boros, among the earliest doctors to use ivermectin, texted, “I try to get three days of ivermectin into them EARLY and they seem to perk up quickly. No hospitalizations, deaths, or vents!”


    Dr. Richard Horowitz, a Lyme disease-turned-covid practitioner, treats aggressively, especially “when you’re talking about 50 percent of the people with mild or no symptoms getting long covid four weeks later.” So does Dr. Ben Marble, who runs MyFreeDoctor.com. “I OVERTREAT rather than under-treat,” he texted me.



    Mary Beth’s positive covid test results.

    Have A Plan

    When a cloud of viral particles drifted silently into my soon-to-be-symptomatic person, I had a half dozen early treatment experts on speed dial. As a journalist who has covered the pandemic since March, 2020, I am fortunate to know doctors who reject the sicken-in-place, see-you-at-the-ER mentality.



    If covid hit, our writer was ready, having bookmarked this page from the FLCCC Alliance months before. (Image Courtesy FLCCC Alliance)

    But even without such access, I would have known what to do. I was already doing it. I had bookmarked the protocols page of the FLCCC. For months, I had been taking vitamins C and D, zinc, curcumin, and quercetin, along with glutathione and n-acetylcycstine in Horowitz’ protocol, with benefits I wrote about early on.


    When I took sick, I continued these supplements and added a few more from the FLCCC list, including nigella sativa, microbe-fighting honey, melatonin, nasal spray and mouthwash.


    The beauty of this: All of these are readily available online or in specialty stores. Moreover, studies, though preliminary, show these nutraceuticals can prevent or alleviate covid and may be enough to treat mild infections.


    “Because ivermectin is so difficult [to get], using the protocols without ivermectin does become a rational thing to do,” said Dr. Paul Marik, a founder of FLCCC, in an interview.


    Unfortunately, that may be the only recourse in the face of a de facto early treatment blockade, epitomized by the FDA-CDC “horse-paste” campaign.



    Early covid treatment means beginning treatment at symptom onset. Mary Beth received this text from Walgreens pharmacy, who would delay her ivermectin prescription by five critical days. Luckily, she was already ready.

    When I needed ivermectin most, Walgreen’s held up my prescription for five crucial days, telling me it was “delayed.” By the time I got it, I was nearly recovered, thanks to my back-up: mail-order ivermectin from India.


    I took the drug under the direction of Dr. Boros, who treated his first patient by cellphone in July of 2020 in a hospital that refused to give the prescription Boros had delivered. The gasping patient took it himself and was breathing easily within 12 hours.


    The lesson: Do not trust the pharmacy system to work. Nor, for that matter, a medical system ruled by agencies that falsely portray decades-old, safe drugs like ivermectin and hydroxychloroquine as dangerous and see “insufficient evidence” to support the no-brainer of covid prevention, Vitamin D.


    ‘Use Famotidine’

    Dr. Robert Malone may be among the world’s leading experts on covid, in particular vaccines. But, like me, he had trouble getting ivermectin when he and his wife, Jill, were infected late in 2021.


    “We were prescribed the full portfolio of agents—which our local pharmacies would not fill,” Malone told me. “(We) ended up self treating with high dose famotidine [also called Pepsid] and adult aspirin.” Both drugs are over-the-counter. The Malones, who are both in their sixties, were better within about a week.


    Malone discovered famotidine’s efficacy during his first run-in with covid in February 2020. “I thought I was going to die,” he told podcaster Joe Rogan. “My lungs were burning until I took famotidine.”


    The drug has been shown effective in a handful of studies, and Malone is continuing his research—using famotidine and celecoxib (Celebrex) in a new clinical trial.


    So what should patients take if they cannot get ivermectin, I asked Dr. Peter McCullough, a crusader for early, sequential, multi-drug covid treatment?


    “If no IVM,” he wrote in an email, “then use famotidine 80 milligrams a day.” McCullough himself took ivermectin and hydroxychloroquine among other drugs for his covid infection, which I documented in an October 2020 article. (His updated Omicron protocol is shown below.)


    Fighting the Blockade

    Indeed, “no IVM” is a common refrain. Last week, a nurse in Virginia shared a voice message with me from a United Parcel Service agent, demanding a prescription and “foreign passport” before delivering ivermectin and fluvoxamine from India. (The company did not respond to three requests for an explanation.)


    Patients in the UK and Canada report similar problems, while Australia has prohibited ivermectin for covid. A New South Wales resident was fined $7,992 for advertising ivermectin and zinc lozenges and claiming they were safe and effective for covid. “Border force is seizing imports,” a resident told me.



    Dr. Mobeen Syed, at home January 14, 2022, recovering from a likely Omicron infection. He was denied ivermectin by a pharmacist before getting sick. Then his physician refused to refer him for approved treatments like monoclonal antibodies. (Photo courtesy of Mobeen Syed)

    But it’s not just generic drugs that are hard to get. Dr. Syed’s pharmacist had earlier refused to fill a prophylactic prescription for ivermectin. So, when he who tested positive for covid last week, he asked his personal physician about government-approved early treatments such as monoclonal antibodies, paxlovid, and molnupiravir.


    Testament to what Syed sees as medicine’s and government’s utter failure to treat, he said the doctor told him approval would be needed from an infectious disease physician. But, believing Syed was ineligible, the doctor was unwilling to seek it on his behalf.


    “We have a very limited supply,” the doctor told him.


    “How embarrassing and shameful,” he said, that even approved covid drugs are not available. “How many people could have been saved if we had given these drugs right in the beginning?”


    Starting with last summer’s myth about poison-control centers overwhelmed with ivermectin calls, the struggle to obtain ivermectin has intensified. Pharmacy delays and refusals are common, escalating since the FDA’s anti-ivermectin advisoryDecember 24 to state medical boards.



    (Illustration by RESCUE; Photo Courtesy of Dr. Peter McCullough)

    The upshot

    It may take some effort and patience, but plan ahead. Here’s how:


    Get the supplements. Two well-supported options: FLCCC’s early treatment menu, and Dr. McCullough’s “six things in the over-the-counter toolbox.” These help prevent covid but also are essential if ivermectin, hydroxychloroquine or fluvoxamine are not available. “With Omicron it’s not as critical that you have those (drugs),” Dr. Kory said. However, “they would assure more recoveries and less long-haul.” Yes, in a perfect world.

    Assemble a list of potential practitioners. Dr. Marble’s MyFreeDoctor just moved to a new platform that will allow the donation-dependent service to add more doctors. “That is how we go from 500 patients a day [now] to 50,000 a day,” he said. The FLCCC and American Association of Physicians and Surgeons also post lists of doctors.

    Search out pharmaceuticals. The appalling practice by pharmacists to flout doctor autonomy and reject prescriptions is forcing patients to order covid generics online. I called a company in India that runs several websites, some of which are listed on a handy how-to-get ivermectin page of the FLCCC.

    Mit Patel, a marketer for the Mumbai-based company, said customers are given tracking numbers, and orders will be reshipped if they get waylaid. Three U.S. customers told me the company delivered without a problem.


    “Very happy to get ivermectin in this pandemic,” said one. I’d note that these drugs should be taken under supervision of a physician, as I did for my relatively uneventful bout of Covid. I believe the drugs helped assure a quick resolution, since I most certainly was infected with Delta.


    Palpable hope. But.

    Some experts are still guarded on covid’s future. Dr. Boros said he is making “no predictions for the future,” while Dr. McCullough said he simply did not know if Omicron will end the pandemic. Some say another mutation could occur; others that it would only make the virus less pathogenic.


    As I researched this article, the emails and texts I received, the news I read, and the comments I heard often made me smile and even tear up. The belief that Omicron is the likely end of the pandemic is causing palpable hope, even amid an unprecedented wave of cases.


    Omicron is clearly a game-changer. In a large new study by researchers from Berkley and Kaiser Permanente, just 1 in 52,272 Omicron patients died, compared to 14 in 16,982 Delta patients.


    In other words, it would take nearly three-quarter million Omicron patients to equal the number who died in that sample of roughly Delta 17,000 patients.


    “Compare this to flu, and it is almost nothing,” Dr. Syed said. “The Omicron death rate is tens of times less than flu now, according to the data from the recent California study.”


    “We need to think about how we can transition from the current pandemic setting to a more endemic setting,” Marco Cavaleri, chief of the European Union’s vaccines committee said in a press briefing January 13, pointing squarely at Omicron. Cavaleri even said, quite astonishingly, that too many boosters could impair the immune system.


    Still, Pfizer promises a likely unnecessary Omicron vaccine by March. Two days ago, I received this text from the New York State Health Department: “Anyone 12+ who received their Pfizer second dose at least five months ago is now eligible for a COVID booster. Get yours today!”


    “We know the boosters don’t work against Omicron,” Dr. Paul Marik, a founder of FLCCC, said in an interview, “yet all you hear is get vaxxed and vaxxed and vaxxed.”


    So will the drive to jab continue even after the pandemic winds down?


    “Yes,” Marik said.



    Anatomy of an antiviral: Nigella sativa (aka black cumin, charnushka, onion seed, and kaloji) has properties against covid that resemble ivermectin’s. (Illustration courtesy of the FLCCC Alliance)

    My Covid Cocktail

    For the record, below is the protocol I took from day one of my covid symptoms. I was fully better within about a week. I was fatigued and glum for another week, the aftermath, I think, of a brush with a disease with potentially long-term implications. I did lose my sense of smell for several weeks afterward; this resolved when, at the recommendation of Dr. Marble, I took 600 milligrams daily of alpha lipoic acid, a supplement I knew from Dr. Horowitz’s protocol. Marble’s eight months of anosmia had resolved with the supplement.


    Ivermectin: 30 milligrams daily, based on 0.4 milligrams per kilogram of my weight, for ten days.


    Supplements: Vitamins D and C, zinc, quercetin, curcumin, nigella sativa, honey, and melatonin.


    Daily practices: Frequent gargling and nasal rinse.


    Famotidine: This was recommended to me by Dr. Malone and is the only drug I took outside the FLCCC protocol; Dr. Kory told me he doesn’t see enough data yet to support it.


    Monoclonal Antibodies: I was nearly better when, on day five of symptoms, I got the infusion. I had read the research. It was available back then to people my age. I went for it

    Quote from Fm1

    “Compare this to flu, and it is almost nothing,” Dr. Syed said. “The Omicron death rate is tens of times less than flu now, according to the data from the recent California study.”

    Glad to hear they see it the same way I do.

    Also times of Israel confirms the high number of silent infections I calculated from recent mass tests.

    Over 71,000 new cases as health officials mull scrapping quarantine for kids
    Serious cases still rising but expert says Israel may be at wave's peak with tens of thousands of undetected daily infections; finance, culture ministers…
    www.timesofisrael.com


    To compare with the Israel positive rate of about 12% and Switzerland with 38%.


    Covid-⁠19 Schweiz | Coronavirus | Dashboard
    Covid-⁠19 Pandemie Schweiz und Liechtenstein: Fallzahlen, Virusvarianten, Hospitalisationen, Re-⁠Wert, Spitalkapazitäten, internationale Lage, Zahlen zu Tests,…
    www.covid19.admin.ch


    Easy to see also that more tests just increase the case numbers. Yesterday be had about 70'000 tests today 100'000 and thus today the positive rate is tick lower...

    Why a 4th COVID-19 Shot Likely Won’t Provide More Protection


    4th COVID-19 Shot Could Weaken Your Immune System
    Experts say our bodies need time to process the stimulation from COVID-19 vaccines and infections before a booster dose is given
    www.healthline.com


    Regulators in Europe say getting too many COVID-19 booster shots may actually weaken your immune system.

    Scientists in Israel also report that a fourth vaccine dose doesn’t appear to produce enough antibodies to protect against an Omicron variant infection.

    Experts explain that our bodies need time to process the stimulation from a vaccine or infection.

    They recommend that people still practice safety protocols such as mask-wearing and physical distancing even if they are fully vaccinated.

    European regulators say giving COVID-19 booster shots too frequently may weaken immune response.


    At a press briefing, experts from the European Medicines Agency (EMA) argued that COVID-19 booster shots should not be given too close together.


    “We are rather concerned about a strategy that entangles repeated vaccination within a short term. We cannot really continuously give a booster dose every 3 or 4 months,” Marco Cavaleri, the head of Biological Health Threats and Vaccines Strategy at the EMA, said at the briefing.


    “If we have a strategy in which we give boosters, let’s say every 4 months approximately, we will end up potentially having a problem with the immune response, and the immune response may end up not being as good as we would like it to be. So we should be careful in not overloading the immune system with repeated immunization,” Cavaleri added.


    In addition, researchers in Israel say a fourth COVID-19 shot doesn’t appear to produce enough antibodies to prevent infection from the Omicron variant.


    This comes as Israel is offering a fourth doseTrusted Source of COVID-19 vaccination to those who work in healthcare and people who are over age 60.


    Dr. William Schaffner, an expert in infectious diseases at Vanderbilt University in Tennessee, says it is crucial to give the immune system time to process what it receives in the initial vaccination series.


    “It’s just well established that the immune system needs some time to process the information that it gets: the stimulus from a vaccine or a natural infection. And then if you want to boost it, you have to give it a certain amount of time to ‘digest’ that information so that it can respond optimally,” Schaffner told Healthline.


    “For example, the traditional hepatitis B vaccine is given as a three-dose series,” he explained. “The first two doses are given a month apart, and then you wait 6 months, or even later, you could wait 2 years. And then the immune system, when it’s stimulated by that third dose, will respond. But you don’t want to give that third dose before 6 months. It’s a little bit counterintuitive, but the immune system often needs some time to process this new information, and in effect, train its troops to respond optimally to that booster dose.”


    Booster recommendations

    The Centers for Disease Control and Prevention (CDC)Trusted Source recommends that everyone over age 12 who received the Pfizer vaccination in the initial vaccination series get a booster at least 5 months after their second dose.


    Those 18 years and older who received the Moderna vaccination in the initial series should get a booster at least 5 months after completing the initial series.


    Adults who received the single dose Johnson and Johnson vaccination should get a booster at least 2 months following their vaccination.


    In early January, the CDC issued guidelinesTrusted Source stating that those who are moderately or severely immunocompromised and have difficulty retaining immunity should get a booster and additional primary shot, for a total of 4 shots. That extra dose is recommended to be at least 5 months after a third shot.


    “In the case of Israel, they’re trying to build a very robust population-level immunity to, in essence, eliminate COVID-19 as a problem. The question is… is it not enough with a third dose, the booster dose?” Dr. Edward C. Jones-Lopez, an assistant professor of clinical medicine at Keck School of Medicine of USC, told Healthline.


    “It’s really about public health authorities trying to understand which is the best strategy here to try and get us out of this mess. Israel has the means to do it,” he said. “They have a relatively small number of people that they can… implement this in an easier way, let’s say compared to other large, somewhat more chaotic countries like the U.S. and some countries in Europe and so on. Each country is pushing, in their own way… trying to get out of this mess.”


    Dr. Otto O. Yang, an infectious disease expert at the University of California Los Angeles, says the four-shot offering occurring in Israel may be a good idea.


    “Based on the fact that immunity against this virus seems intrinsically short-lived, which is why immunity from the vaccines is short-lived, this is probably a good idea. The fact that the virus has evolved into Omicron is what has sped up the need for boosters — the antibodies against the vaccine are targeted against the original strain, and so much higher levers are needed against Omicron,” Yang told Healthline.


    “If the vaccines were adapted against Delta and Omicron, immunity would last much longer because lower levels of antibodies would be needed since those antibodies are directly targeted against those variants,” he added

    Scientist surprised by discovery of ‘99%’ effective, cheap COVID treatment


    Scientist surprised by discovery of ‘99%’ effective, cheap COVID treatment
    The scientist who combined two widely available over-the-counter compounds that inhibited the novel coronavirus by 99% in early tests told WND he's hopeful his…
    www.clarkcountytoday.com


    Scientist surprised by discovery of ‘99%’ effective, cheap COVID treatment


    University of Florida researcher tells WND people already reporting results from Benadryl

    Art Moore

    WND News Center


    The scientist who combined two widely available over-the-counter compounds that inhibited the novel coronavirus by 99% in early tests told WND he’s hopeful his treatment will be available “within months.”



    “An FDA-approved treatment could be in sight within months if pharmaceutical companies utilize existing clinical trial resources,” said Dr. David Ostrov in an email interview with WND.


    Ostrov, an immunologist and associate professor in the University of Florida College of Medicine’s department of pathology, immunology and laboratory medicine, combined diphenhydramine, which is marketed as Benadryl, and lactoferrin, a protein in milk, as WND reported in December.


    “My prediction is that antiviral drug combinations, such as diphenhydramine and lactoferrin, will provide a similar level of benefit as Regeneron monoclonal antibodies, Pfizer and Merck antivirals, at less than 1/100 the cost of those therapies,” he told WND.


    Ostrov said he knew he was facing an uphill battle in his effort to find a combination of cheap, safe and available drugs to combat COVID-19.


    “I expected failure, but you never know until you try,” he said. “My reaction was surprise.”


    His study, with early results showing 99% efficacy in inhibiting replication of the SARS-CoV-2 virus, was published Nov. 20 in the journal Pathogens.


    Ostrov told WND he’s been in communication with people who wonder if their use of the compounds has helped prevent them from getting COVID-19.


    He noted that “anecdotal stories are certainly not proof of efficacy,” but many people have contacted him about diphenhydramine and lactoferrin, and their results “are difficult to ignore.”


    “For many people, they say everyone around them got COVID, but not them,” Ostrov said.


    And they ask the professor if diphenhydramine and/or lactoferrin.


    “Without placebo controlled clinical trials, we will not have a definitive answer,” he said. “The answer for now, though, is maybe.”


    Ostrov mentioned a contact who takes a daily dose of Benadryl and regularly drinks milk. She said she had been in close contact for hours with someone who was hospitalized the next day for COVID-19. But after waiting five days from the time of exposure, she tested negative for COVID.


    He cautioned that people “considering their own concoction should understand that our experiments were carried out with human lactoferrin, not cow.” And the lactoferrin he used was purified in a special way to enhance its antiviral properties and is not likely to be found on the shelf.


    People should consult with their physician, Ostrov said, before taking any drug for a use other than its intended use.


    “Even though historically there are relatively few adverse events reported for diphenhydramine and lactoferrin, it should be noted that long term use of any medication, or combination of medications, could have unexpected consequences,” he said.


    Ostrov said he hopes that once FDA-approved, “people may benefit from this antiviral drug combination for two-to-three month intervals during each wave of COVID infections.”

    Read the Q&A:

    WND: I imagine there was elation in finding 99% effectiveness in inhibiting replication of the virus that has changed the world. Can you describe your reaction and your hopes for this possible treatment?


    DR. OSTROV: We were aiming to find a combination of drugs that would work much better against SARS-CoV-2 when used together. I expected failure, but you never know until you try. My reaction was surprise.


    My hope is that this antiviral drug combination will be shown to both prevent and treat COVID effectively (in placebo controlled clinical trials).


    Since these drugs are stable at room temperature, economical, widely available and have long histories of safety, diphenhydramine and lactoferrin have the potential to inhibit replication of the coronavirus (and the emergence of new variants) on a global scale.


    WND: Can you explain in layman’s terms why these two compounds appear to be effective in inhibiting SARS-CoV-2?


    DR. OSTROV: SARS-CoV-2 causes cells to undergo stress in a way that creates a good environment for the virus to replicate.


    Diphenhydramine binds a specific protein involved in cell stress and blocks the virus from creating a good environment for replication.


    Lactoferrin has antiviral activity for different reasons. Lactoferrin is thought to repel virus particles from target cells (by binding lipoproteins on cell surfaces). Lactoferrin is also thought to suppress virus replication.


    WND: How did you come to find out that diphenhydramine was potentially effective against COVID-19?


    DR. OSTROV: The story started before SARS, when my lab was studying drugs that bind ACE2, the molecule that turned out to be the receptor for SARS and SARS-CoV-2.


    We previously found that an antihistamine (hydroxyzine) bound ACE2, and in 2020 were able to test the ability of this drug to inhibit SARS-CoV-2 in the lab. It was an “aha” moment when the data clearly showed that a common antihistamine inhibited the virus that causes COVID. Different scientists at the University of Florida College of Medicine used different isolates of SARS-CoV-2, and the results agreed with each other. An antihistamine can inhibit the virus!


    We then realized that there may be similar drugs that could inhibit the virus, perhaps even over-the-counter drugs. But which drugs?


    We collaborated with investigators and UCSF where they examined the medical records for more than 219,000 people tested for SARS-CoV-2. They found that usage of diphenhydramine was associated with a lower incidence of SARS-CoV-2. In other words, in this population, people were less likely to be infected with COVID if they used diphenhydramine.


    Why would taking an allergy pill lead to lower risk of COVID? There could be many reasons, but is it possible that a simple allergy pill can directly inhibit the virus that causes COVID?


    We did the experiments at the University of Florida College of Medicine, and the data was published in a peer reviewed journal. Diphenhydramine exhibits direct antiviral activity against SARS-CoV-2. Diphenhydramine inhibits virus replication, inhibits virus shedding and inhibits host cell killing.


    WND: Obviously, treatments for COVID-19 are needed now, but further research and human trials are necessary, which take time. Assuming the further trials affirm your early findings, how long might it be before such a treatment is available to the public?


    DR. OSTROV: An FDA-approved treatment could be in sight within months if pharmaceutical companies utilize existing clinical trial resources.


    My prediction is that antiviral drug combinations, such as diphenhydramine and lactoferrin, will provide a similar level of benefit as Regeneron monoclonal antibodies, Pfizer and Merck antivirals, at less than 1/100 the cost of those therapies.


    WND: What is your caution to people who might try their own concoction, perhaps with Benadryl and lactoferrin? Could there be any harmful consequences?


    DR. OSTROV: People considering their own concoction should understand that our experiments were carried out with human lactoferrin, not cow. The lactoferrin we used was purified in a special way to enhance its antiviral properties. People are not likely to find this on the shelf.


    Could there be harmful consequences? People should consult with their physician before taking any drug “off-label,” meaning using a drug for a use other than its intended use.


    Even though historically there are relatively few adverse events reported for diphenhydramine and lactoferrin, it should be noted that long term use of any medication, or combination of medications, could have unexpected consequences.


    My hope is that people may benefit from this antiviral drug combination for two-to-three month intervals during each wave of COVID infections.


    WND: Are there any treatments for COVID-19 available now that you have found to be effective?


    DR. OSTROV: Current treatments seem to speed up recovery, but not as dramatically as we would like. We can expect that many monoclonal antibodies used for treatment will exhibit reduced effectiveness as circulating viruses acquire more mutations, such as in omicron.


    Based on our understanding of the mechanism of action, mutations in the spike protein are not expected to impact the antiviral activities of diphenhydramine and lactoferrin. This is important because it means that we may be able to inhibit the virus regardless of mutations that arise in the spike protein.

    Quote from Wyttenbach

    Israel :: It is now 100% clear that boosters show 0 effect at all. The ratio of 2x vaxx :: 3x vaxx in new severe patients corresponds to the vaxx ratio... But 3xx vaxx is more likely to get a severe infection than no vaxx. - Most likely due to age and missing infection/recovered...

    https://datadashboard.health.gov.il/COVID-19/general

    14% of Israelis are unvaxxed. They are 100% of ECMO patients
    ***
    www.haaretz.com


    Just wanted to add this to the topic of myocarditis risk, compared with "pre-corona" data...good read.


    Getting COVID-19 is much riskier for your heart than vaccination
    Myocarditis — an inflammation of the heart muscle — following COVID-19 vaccination is rare, and the risk is much smaller than the risks of cardiac injury…
    www.pbs.org

    Quote from Fm1

    Dr. Mollie James turned covid around for her brother, Nick James, by treating him at home with high-dose ivermectin for ten days, hydroxychloroquine for five days, a blood thinner, intravenous vitamin C, and—the ultimate breakthrough— four days of hyperbaric oxygen treatments. He returned to his job as an insurance agent in Iowa the next week. (Photo courtesy of Mollie James)

    Omicron is tearing through the country, with Covid cases quadrupling and quintupling in thirty-five states from last winter’s peak.


    This just does not make sense, it confused coincidence with causality.


    COVID is a nasty disease which mots people (99.5%) recover from. The fact that somone had COVID, with severe symptoms, and recovered from it is...

    normal


    There is no possible way that those involved with administering whatever drugs they like to such a patient can no whether those drugs made things better or worse.


    More, given three interventions, if they were proven to have some effect, say by and RCT with a few hundred patients, you still would not know which was having the effect. One might even be making things worse, counteracted by the other two.


    I think the people who report this don't have a clue. (Perhaps they are antivaxxers :) )


    THH

    Or perhaps not! Thousands if not millions say YOU are wrong. Ask the citizens of India who have no Covid.

    14% of Israelis are unvaxxed. They are 100% of ECMO patients
    ***
    www.haaretz.com


    Clowns are back referencing fake studies about Israel and IVR. I wonder whether it is a joy to kill people or whether here is the only space where they can fully live out their fascist nature.


    Fact is most new serious Israel cases are among boostered. Most deaths currently are among 2xx/3xx/4xx vaccinated. And 30% are not vaccinated in Israel not as the Haaretz fake claims 15%... Studies older than one week won't help here for Omicron actual situation....

    Also in Switzerland the trend is clear. With Omicron more vaccinated than unvaxx end up in hospital. (This are the absolute numbers!)

    Covid-⁠19 Schweiz | Coronavirus | Dashboard
    Covid-⁠19 Pandemie Schweiz und Liechtenstein: Fallzahlen, Virusvarianten, Hospitalisationen, Re-⁠Wert, Spitalkapazitäten, internationale Lage, Zahlen zu Tests,…
    www.covid19.admin.ch


    The number "unbekannt" means type of vaccine not known.


    The good news is:: Despite 10x cases hospitalizations are stable at 1/3 below September maximum...


    So don't worry except you are not yet a recovered and high risk.

    What is the "one cold fusion patent granted by the European patent office", listed in Wikipedia cold fusion in the patent section?




    Patents    Edit

    Although details have not surfaced, it appears that the University of Utah forced the 23 March 1989 Fleischmann and Pons announcement to establish priority over the discovery and its patents before the joint publication with Jones.[33] The Massachusetts Institute of Technology (MIT) announced on 12 April 1989 that it had applied for its own patents based on theoretical work of one of its researchers, Peter L. Hagelstein, who had been sending papers to journals from 5 to 12 April.[180]On 2 December 1993 the University of Utah licensed all its cold fusion patents to ENECO, a new company created to profit from cold fusion discoveries,[181]and in March 1998 it said that it would no longer defend its patents.[79]

    The U.S. Patent and Trademark Office(USPTO) now rejects patents claiming cold fusion.[93] Esther Kepplinger, the deputy commissioner of patents in 2004, said that this was done using the same argument as with perpetual motion machines: that they do not work.[93] Patent applications are required to show that the invention is "useful", and this utility is dependent on the invention's ability to function.[182] In general USPTO rejections on the sole grounds of the invention's being "inoperative" are rare, since such rejections need to demonstrate "proof of total incapacity",[182] and cases where those rejections are upheld in a Federal Court are even rarer: nevertheless, in 2000, a rejection of a cold fusion patent was appealed in a Federal Court and it was upheld, in part on the grounds that the inventor was unable to establish the utility of the invention.[182][notes 8]

    A U.S. patent might still be granted when given a different name to disassociate it from cold fusion,[183]though this strategy has had little success in the US: the same claims that need to be patented can identify it with cold fusion, and most of these patents cannot avoid mentioning Fleischmann and Pons' research due to legal constraints, thus alerting the patent reviewer that it is a cold-fusion-related patent.[183] David Voss said in 1999 that some patents that closely resemble cold fusion processes, and that use materials used in cold fusion, have been granted by the USPTO.[184] The inventor of three such patents had his applications initially rejected when they were reviewed by experts in nuclear science; but then he rewrote the patents to focus more on the electrochemical parts so they would be reviewed instead by experts in electrochemistry, who approved them.[184][185] When asked about the resemblance to cold fusion, the patent holder said that it used nuclear processes involving "new nuclear physics" unrelated to cold fusion.[184] Melvin Miles was granted in 2004 a patent for a cold fusion device, and in 2007 he described his efforts to remove all instances of "cold fusion" from the patent description to avoid having it rejected outright.[186]


    At least one patent related to cold fusion has been granted by the European Patent Office.[187]


    A patent only legally prevents others from using or benefiting from one's invention. However, the general public perceives a patent as a stamp of approval, and a holder of three cold fusion patents said the patents were very valuable and had helped in getting investments.[184]

    2022-01-19 02:15 Roberto 

    Dr Rossi,

    You received so far orders for more than 600000 Units of Ecat Skleds after the publication of the video – presentation of December 9th. Curiosity: can you tell us moreless from how many clients ?

    Best,

    Roberto

    P.S.

    Congratulations for the excellent video I watched the link of in E-Catworld: simple, clear, essential like a cuttlefish bone and convincing


    2022-01-19 06:38 Andrea Rossi 

    Roberto:

    About one thousand

    Warm Regards,

    A.R.

    like "I can't believe its not butter" vs butter tests in blood work after 3 months of each. you'll know the stats told to benefiting the dollar junk then the $5, The systems been doing this a very long time

    ps, if you end up in the er and lots of meds are pushed when you get home, maybe after a stroke rethink what you are told, likely talking to a cp will just get you another pill. frustrating....

    You don't get the loan from the bank unless you sign the paperwork type deal.

    All for the care -release of responsibility ...

    Wikipedia is so wrong


    2007 SPAWAR Patent “System and method for generating particles” US8419919B1 Filing: Sep 21, 2007 - Publication: Apr 16, 2013 Assignee: JWK International Corporation, The United States Of America As Represented By The Secretary Of The Navy - GRANT Issued: Apr 16, 2013 Inventors: Pamela A. Boss, Frank E. Gordon, Stanislaw Szpak, Lawrence Parker Galloway Forsley https://www.google.com/patents/US8419919B1


    Maybe Wiki is talking about this one.

    This following patent was first filed at the European Patent Office. JWK opened an office in London for one year at that time. It seems that office was only opened to file this patent outside of the US.


    2008 Patent (SPAWAR JWK LENR tech) “A hybrid fusion fast fission reactor” WO2009108331A2 - Publication date: Dec 30, 2009 - Priority date: Feb 25, 2008 Inventors: Lawrence Parker Galloway Forsley, Jay Wook Khim - Applicant: Lawrence Parker Gallow Forsley https://www.google.com/patents/WO2009108331A2


    2016 NASA Patent “Methods and apparatus for enhanced nuclear reactions” US20170263337A1 https://patents.google.com/patent/WO2017155520A1/en


    Apparatus And Method For Sourcing Fusion Reaction Products

    US20210151206A1 - Apparatus And Method For Sourcing Fusion Reaction Products - Google Patents

    2020-03-02 Assigned to GOOGLE INC.

    2020-12-16 Assigned to UNITED STATES DEPARTMENT OF ENERGY

    [0002] This invention was made with government support under Contract No. DE-AC02-05CH11231 awarded by the U.S. Department of Energy. The government has certain rights in this invention.


    Target Structure for Enhanced Electron Screening US10264661B2

    Assignee: Google Inc.

    US10264661B2 - Target structure for enhanced electron screening - Google Patents

    I really wonder what goes on in someone's mind who writes stuff like that and then answers himself, probably thinking no one will realize. I see severe pathological issues here.

    Sometimes I am surprised when I find an old US government cold fusion patent that everyone missed.


    Has this interesting solid state CMNS energy technology patent been discussed here?


    Steady-state, high dose neutron generation and concentration apparatus and method for deuterium atoms

    US5949835A - Steady-state, high dose neutron generation and concentration apparatus and method for deuterium atoms - Google Patents

    Abstract

    A steady-state source of neutrons is produced within an electrically grounded and temperature controlled chamber confining tritium or deuterium plasma at a predetermined density to effect implantation of ions in the surface of a palladium target rod coated with diffusion barrier material and immersed in such plasma. The rod is enriched with a high concentration of deuterium atoms after a prolonged plasma ion implantation. Collision of the deuterium atoms in the target by impinging ions of the plasma initiates fusion reactions causing emission of neutrons during negative voltage pulses applied to the rod through a high power modulator. The neutrons are so generated at a relatively high dose rate under optimized process conditions.

    Images (4)

    US5949835-drawings-page-3.png US5949835-drawings-page-4.png US5949835-drawings-page-5.png US5949835-drawings-page-6.png

    Classifications


    H05H3/06 Generating neutron beams

    G21B3/00 Low temperature nuclear fusion reactors, e.g. alleged cold fusion reactors

    Y02E30/10 Nuclear fusion reactors

    US5949835A

    United States

    Inventor

    Han S. Uhm

    Woodrow W. Lee


    Current Assignee US Department of Navy


    US Application US07/724,083 events


    1991-07-01 Application filed by US Department of Navy


    1991-07-01 Priority to US07/724,083  

    1991-07-19 Assigned to UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE NAVY


    1999-09-07 Application granted


    1999-09-07 Publication of US5949835A


    2016-09-07 Anticipated expiration

    Quote from Wyttenbach

    https://www.haaretz.com/israel…-serious-cases-1.10530817


    Clowns are back referencing fake studies about Israel and IVR. I wonder whether it is a joy to kill people or whether here is the only space where they can fully live out their fascist nature.


    Fact is most new serious Israel cases are among boostered. Most deaths currently are among 2xx/3xx/4xx vaccinated. And 30% are not vaccinated in Israel not as the Haaretz fake claims 15%... Studies older than one week won't help here for Omicron actual situation....

    Israel’s Vaccine Chief on the Record: COVID-19 mRNA Vaccines Failed to Protect Israel by providing ‘Sterilizing Immunity’


    Israel’s Vaccine Chief on the Record: COVID-19 mRNA Vaccines Failed to Protect Israel by providing ‘Sterilizing Immunity’
    Israel served as a sort of canary in the mine for the United States, Britain, and other nations in the “West” during the COVID-19 pandemic. Rapidly
    trialsitenews.com


    Israel served as a sort of canary in the mine for the United States, Britain, and other nations in the “West” during the COVID-19 pandemic. Rapidly adopting the novel COVID-19 mRNA-based vaccines, Israel used its small, condensed population and strong government in an unprecedented rapid mass vaccination program. With the highest booster rates in the world, Israel now embraces the fourth booster jab in just over a year. While the vaccines have, according to the Israeli Ministry of Health, reduced rates of hospitalization and death, TrialSite chronicled major waves of breakthrough infections there, including so-called breakthrough hospitalizations and death during the Delta variant-driven surge and now again with record numbers of new infections with the Omicron surge. Cyrille Cohen’s voice carries significant influence in Israel in all matters of COVID-19 as the professor and head of Immunology at Bar Ilan University, not to mention a member of the government’s advisory committee for vaccines. Cohen declared in a recent interview with a British conservative upstart media that Israel’s COVID-19 vaccine passport program probably won’t be relevant soon given challenges with Omicron, suggesting the program could be phased out. Predicting that the Israeli government will, in fact, eliminate such improper policies sooner rather than later, the top immunologist shared in this interview that he and colleagues are of the opinion that the COVID-19 vaccines fell far short of their purported goal of stopping SARS-CoV-2 transmission. The thought leader went on the record, questioning their approach—such as shutting down schools, business, and the like—along with other measures that shook up Israeli society in a desperate attempt to avoid mass infection as well as the dangers of hospitalization and death associated COVID-19. Cohen now acknowledges that “widespread infection is now an inevitable part of future immunity,” also known as “herd immunity.”


    The Expert

    A notable key opinion leader, Professor Cyrille Cohen currently works as Principal Investigator with the title of Head of the Laboratory of Tumor Immunology and Immunotherapy at Bar Ilan University.


    Educated at Israel Institute of Technology, Cohen earned his BSc, MSc, and Ph.D. in Immunology and Biology. Dr. Cohen runs a lab named after him which centers on investigations into immunology associated with cancer.


    The Interview

    Recently interviewed on the conservative new media startup UnHerd, interviewer Freddie Sayers took in a recognition by one of Israel’s top immunologists that “mistakes were made” in Israel.



    With nearly 70% of the population fully vaccinated and over 50% boosted with the mRNA vaccine, the government now initiates a fourth booster dose.


    Sayers pointed out Israel’s importance in the global pandemic response in the West. America and many countries in Europe, such as the UK, look to Israel as “an example to follow,” given they were a fist to implement stringent travel restrictions. Israel also boasted the fastest COVID-19 mass vaccination implementation all backed by a “muscular” government believing the “virus could be controlled.”


    Of course, with Omicron-based cases raging the opposite is very much the case. Dr. Cohen, starting with what was most certainly guarded language, offered what some could interpret as bombshell admissions.


    In the first part of the interview, Cohen declared:


    “Today we are in a different phase of the pandemic. We are in a different stage of what we call COVID-19.


    Israel, where we were the first to immunize massively, exactly a year ago in January and February, enabled us to actually end lockdowns since March. Even before that, from February on, we started to open our economy, our society. And then we were confronted. We were the first to notice a decrease in the waning of the immunity following the second shot, and that’s when we had to decide, and believe me, it wasn’t an easy decision to decide that we needed a third shot, a booster shot. And we did that, and it helped us minimize the consequences of what we call here the fourth wave. And then Omicron happened.


    And Israel, I would say quite intelligently, closed its border again, which enabled us to get prepared during a month, where we had almost no cases of Omicron here. But again, we cannot delay that indefinitely. And now, we have Omicron.”


    What have they learned according to the top Israeli immunologist?


    The COVID-19 vaccines are excellent at preventing severe SARS-CoV-2

    Unfortunately, the durability of the vaccines are a real problem—their effectiveness against infection wanes or reduces in a short period of time—a major lesson for the world

    When asked by Sayers if the durability issue was a surprise, the Israeli scientist responded with a resounding “yes.” Cohen shared that scientists and health experts in Israel were quite bullish about the vaccine’s effectiveness after dealing with a deadly month last January, thanks to the initial vaccination push: not only did cases rapidly decline but society opened back up. Many of his colleagues thought the pandemic was “over” thanks to the Pfizer vaccine, and the situation unfolded from April through part of summer 2020.


    On the assumption that the mRNA vaccine stopped viral transmission, Cohen shared, “We did believe at that time [spring of 2021] that vaccines can prevent transmission.”


    But Cohen qualified this blocking of transmission was short-lived, and “not over a long period of time.” Thus, going on the record, he reported that they were surprised by the Pfizer vaccine’s questionable durability.


    Several studies emerged in summer 2021 that indicated that the Pfizer vaccine’s effectiveness waned in a matter of a few months, which is by no means long in duration.


    Cohen and colleagues were most certainly surprised as to the durability challenges stating, “at the end of the day the vaccines are not protecting us, they are not causing what we call sterilizing immunity.”


    External Content youtu.be
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.